Katayama Y - Search Results

1

Outcome and Risk Factors for Therapy-Related Myeloid Neoplasms Treated with Allogeneic Stem Cell Transplantation in Japan.

Kida M, Usuki K, Uchida N, Fukuda T, Katayama Y, Kondo T, Eto T, Matsuoka KI, Matsuhashi Y, Ota S, Sawa M, Miyamoto T, Ichinohe T, Kimura T, Atsuta Y, Takami A, Miyazaki Y, Yano S, Ishiyama K, Yanada M, Aoki J. Kida M, et al. Among authors: katayama y. Biol Blood Marrow Transplant. 2020 Aug;26(8):1543-1551. doi: 10.1016/j.bbmt.2020.04.004. Epub 2020 Apr 19. Biol Blood Marrow Transplant. 2020. PMID: 32320746 Free article.

2

Early central nervous system complications after reduced-intensity stem cell transplantation.

Kishi Y, Miyakoshi S, Kami M, Ikeda M, Katayama Y, Murashige N, Kusumi E, Yuji K, Kobayashi K, Kato D, Hamaki T, Matsumura T, Kim SW, Morinaga S, Mori S, Kanemaru M, Hayashi T, Takaue Y, Taniguchi S; Tokyo Stem Cell Transplantation Consortium. Kishi Y, et al. Among authors: katayama y. Biol Blood Marrow Transplant. 2004 Aug;10(8):561-8. doi: 10.1016/j.bbmt.2004.05.004. Biol Blood Marrow Transplant. 2004. PMID: 15282534 Free article.

3

Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.

Murashige N, Kami M, Mori S, Katayama Y, Kobayashi K, Onishi Y, Hori A, Kishi Y, Hamaki T, Tajima K, Kanda Y, Tanosaki R, Takaue Y. Murashige N, et al. Among authors: katayama y. Am J Hematol. 2008 Aug;83(8):630-4. doi: 10.1002/ajh.21197. Am J Hematol. 2008. PMID: 18454459 Free article.

4

Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation.

Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, Ota S, Moriyama M, Ikezoe T, Miyazaki Y, Hayashi K, Fujita S, Satake A, Ito T, Kyo T, Tanimoto M. Nomura S, et al. Among authors: katayama y. J Blood Med. 2016 Jan 18;7:1-4. doi: 10.2147/JBM.S93008. eCollection 2016. J Blood Med. 2016. PMID: 26848281 Free PMC article.

5

[Post-allogeneic stem cell transplant extramedullary relapse of acute megakaryoblastic leukemia initially detected by elevated WT1 mRNA levels in peripheral blood].

Ochi T, Iwato K, Katayama Y, Toishigawa K, Okatani T, Imanaka R, Kyo K, Itagaki M, Katsutani S, Asaoku H, Kyo T. Ochi T, et al. Among authors: katayama y. Rinsho Ketsueki. 2016;57(11):2319-2323. doi: 10.11406/rinketsu.57.2319. Rinsho Ketsueki. 2016. PMID: 27941279 Japanese.

6

[Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by concomitant Achromobacter xylosoxidans and Corynebacterium striatum bacteremia following allogeneic hematopoietic stem cell transplantation].

Katayama Y, Kyo K, Iwato K, Okatani T, Imanaka R, Itagaki M, Katsutani S, Asaoku H. Katayama Y, et al. Rinsho Ketsueki. 2017;58(11):2250-2255. doi: 10.11406/rinketsu.58.2250. Rinsho Ketsueki. 2017. PMID: 29212977 Japanese.

7

[Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].

Imanaka R, Katayama Y, Iwato K, Kyo K, Okatani T, Itagaki M, Katsutani S, Asaoku H. Imanaka R, et al. Among authors: katayama y. Rinsho Ketsueki. 2018;59(1):58-63. doi: 10.11406/rinketsu.59.58. Rinsho Ketsueki. 2018. PMID: 29415939 Review. Japanese.

8

Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning.

Harada K, Yanada M, Machida S, Kanamori H, Onizuka M, Ozawa Y, Kobayashi H, Sawa M, Katayama Y, Ohashi K, Kanda J, Ichinohe T, Atsuta Y, Yano S. Harada K, et al. Among authors: katayama y. Leuk Lymphoma. 2019 Jun;60(6):1493-1502. doi: 10.1080/10428194.2018.1535115. Epub 2018 Nov 20. Leuk Lymphoma. 2019. PMID: 30457400

9

Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.

Nomura S, Ito T, Katayama Y, Ota S, Hayashi K, Fujita S, Satake A, Ishii K. Nomura S, et al. Among authors: katayama y. Transpl Immunol. 2019 Apr;53:28-33. doi: 10.1016/j.trim.2018.12.001. Epub 2018 Dec 10. Transpl Immunol. 2019. PMID: 30543860

10

Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.

Yanada M, Mori J, Aoki J, Masuko M, Harada K, Uchida N, Doki N, Fukuda T, Sakura T, Kanamori H, Sawa M, Kondo T, Katayama Y, Kanda J, Ichinohe T, Atsuta Y, Yano S. Yanada M, et al. Among authors: katayama y. Ann Hematol. 2019 Sep;98(9):2179-2186. doi: 10.1007/s00277-019-03736-5. Epub 2019 Jun 15. Ann Hematol. 2019. PMID: 31203422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,810 results

Search Page

Filters